BeStock  
Stocks › Biotechnology › AKTS

Aktis Oncology AKTS

US equityMarket cap rank #3226Biotechnology
$16.15 −$0.25 (-1.52%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $16.46 +1.92%
Open$16.32
Prev close$16.40
Day range$16.00 – $16.74
Volume375.0K
Market cap$901.14M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts4
Average target$36.50+126.0% vs. price
  • Buy 100%
Low $34.00Now $16.15Avg $36.50High $40.00

Recent rating changes

The last 20 actions on file set price targets from $33.00 to $40.00, averaging $36.19.

DateFirmRatingTarget
13 Nov 2026 BofA Securities BUY $34.00
13 Nov 2026 Oppenheimer BUY $40.00
2 Oct 2026 Wedbush BUY $35.00
9 Sep 2026 Oppenheimer BUY $40.00
19 Aug 2026 Wedbush BUY $35.00
18 Aug 2026 BMO Capital BUY $37.00
14 Aug 2026 William Blair BUY –
14 Aug 2026 BofA Securities BUY $34.00
14 Aug 2026 J.P. Morgan BUY $33.00
14 Jul 2026 William Blair BUY –
14 Jul 2026 J.P. Morgan BUY $33.00
16 Jun 2026 Raymond James BUY $40.00
15 Jun 2026 Raymond James BUY $40.00
12 Jun 2026 Raymond James BUY $40.00
3 Jun 2026 H.C. Wainwright BUY $35.00
2 Jun 2026 H.C. Wainwright BUY $35.00
1 Jun 2026 William Blair BUY –
31 May 2026 BofA Securities BUY $34.00
27 May 2026 William Blair BUY –
27 May 2026 BofA Securities BUY $34.00

Discussion

No comments yet — be the first to weigh in on AKTS.

Sign in to join the discussion.

Scroll to Top